Achatz MI, Olivier M, Le Calvez F, et al. The TP53 mutation,
R337H, is associated with Li-Fraumeni and Li-Fraumeni-like
syndromes in Brazilian...
Ferreira AM, Brondani VB, Helena VP, et al. Clinical spectrum
of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with...
Guha T, Malkin D. Inherited TP53 mutations and the LiFraumeni syndrome. Cold Spring Harb Perspect Med. 2017;7(4):
a026187. https://doi.org/10.1101/cshperspect.a026187.
Akay BN, Okcu Heper A, Topcu V, Farabi B. A rare case of
multiple cutaneous melanomas in Li-Fraumeni syndrome: a
coincidental association...
Hartley AL, Birch JM, Marsden HB, Harris M. Malignant
melanoma in families of children with osteosarcoma,
chondrosarcoma, and adrenal cortical...
Almashali M, Ellis R, Paragh G. Melanoma epidemiology,
staging and prognostic factorsEn, Practical manual for dermatologic and surgical melanoma...
Markovic SN, Erickson LA, Rao RD, et al. Malignant melanoma
in the 21st century, part 1: epidemiology, risk factors,
screening, prevention,...
Cho E, Rosner BA, Colditz GA. Risk factors for melanoma by
body site. Cancer Epidemiol Biomarkers Prev. 2005;14(5):
1241–1244. https://doi.org/10.1158/1055-9965.EPI-04-0632.
Murali S, Logue ME, Talamantes Y, Berwick M. Melanoma
epidemiology and preventionEn, Melanoma. Cham: Springer
International Publishing; 2018....
Satyamoorthy K, Chehab NH, Waterman MJ, et al. Aberrant
regulation and function of wild-type p53 in radioresistant
melanoma cells. Cell Growth...
Shieh SY, Ahn J, Tamai K, Prives C. The human homologs of
checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53
at multiple DNA damage-inducible...
Hirao A, Kong Y-Y, Matsuoka S, et al. DNA damage-induced
activation of p53 by the checkpoint kinase Chk2. Science. 2000;
287(5459):1824–1827....
Bougeard G, Renaux-Petel M, Flaman J-M, et al. Revisiting LiFraumeni syndrome from TP53 mutation carriers. J Clin Oncol.
2015;33(21):2345–2352....
Giavedoni P, Ririe M, Carrera C, Puig S, Malvehy J. Familial
melanoma associated with Li-fraumeni syndrome and atypical mole syndrome: total-body...
Black AC. A patient with stage 3 melanoma and serendipitously discovered Li Fraumeni syndrome. Proceedings of UCLA
Health. 2019;23 vol.
Villani A, Shore A, Wasserman JD, et al. Biochemical and
imaging surveillance in germline TP53 mutation carriers with
Li Fraumeni syndrome:...
Klein JD, Kupferman ME. Li-Fraumeni syndrome presenting as
mucosal melanoma: case report and treatment considerations: Li-Fraumeni syndrome...
Jebain J, Siller Jr A, Gill P, Prieto VG, Tyring SK. Recurrence of
mucosal melanoma in Li-Fraumeni syndrome: a follow-up of
an index case....
Baek YS, Seo JY, Song JY, Lee S-Y, Kim A, Jeon J. Li-Fraumeni
syndrome presenting as cutaneous melanoma in a child: case
report and review...
Kollipara R, Cooley LD, Horii KA, et al. Spitzoid melanoma in a
child with Li-Fraumeni syndrome. Pediatr Dev Pathol. 2014;17
(1):64–69. https://doi.org/10.2350/13-09-1380-CR.1.
Kratz CP, Achatz MI, Brugières L, et al. Cancer screening
recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res. 2017;23(11):e38–e45....
Lo Piccolo L, Jantrapirom S, Moonmuang S, et al. In search of
TP53 mutational hot spots for Li-Fraumeni syndrome in Asian
populations. Trop...
Kamihara J, Rana HQ, Garber JE. Germline TP53 mutations and
the changing landscape of Li-Fraumeni syndrome. Hum Mutat.
2014;35(6):654–662....
Correa H. Li-Fraumeni syndrome. J Pediatr Genet. 2016;5(2):
84–88. https://doi.org/10.1055/s-0036-1,579,759.
Formiga MNDC, De Andrade KC, Kowalski LP, Achatz MI.
Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H
carriers with Li Fraumeni syndrome....
Pinto EM, Zambetti GP. What 20 years of research has taught
us about the TP53 p.R337H mutation. Cancer. 2020;126(21):
4678–4686. https://doi.org/10.1002/cncr.33143.
Valdez JM, Nichols KE, Kesserwan C. Li-Fraumeni syndrome: a
paradigm for the understanding of hereditary cancer predisposition. Br J Haematol....
Regan H, Marren P. Melanoma and Li-Fraumeni syndrome:
family history is not essential for screening recommendation.
Clin Exp Dermatol. 2021;46(8):1567–1568....
Mai PL, Best AF, Peters JA, et al. Risks of first and subsequent
cancers among TP53 mutation carriers in the National Cancer
Institute Li-Fraumeni...
Nieuwenburg SA, Adan F, Ruijs MWG, Sonke GS, Van Leerdam
ME, Crijns MB. Cumulative risk of skin cancer in patients with
Li-Fraumeni syndrome....
Pflugfelder A, Kochs C, Blum A, et al. Malignant melanoma S3-
guideline «diagnosis, therapy and follow-up of melanoma».
J Dtsch Dermatol Ges....
Salerni G, Teran T, Puig S, et al. Meta-analysis of digital
dermoscopy follow-up of melanocytic skin lesions: a study on
behalf of the International...
Alarcón I, Carrera C, Palou J, Alos L, Malvehy J, Puig S. Impact
of in vivo reflectance confocal microscopy on the number
needed to treat...
